Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Intra-Cellular Therapies

Youtube Subscribe

...

Ticker: ITCI

Sector: Pharmaceuticals

Intra-Cellular Therapies, Inc. focuses on the discovery, clinical development, and commercialization of small molecule drugs. The company offers CAPLYTA for schizophrenia and bipolar depression in adults. It is also developing Lumate.
...
...
Extended Summary

Intra-Cellular Therapies

Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also involved in developing Lumateperone, which is in Phase 3 clinical trial for the treatment of various depressive disorders, as well as additional neuropsychiatric indications. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease, heart failure, CNS, and other disorders; ITI-1284 for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression, anxiety, and sleep disorders. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.

Related Results

...
January 25, 2024 22:44 (London Time)

Intra-Cellular Therapies

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Forecasted to Earn Q1 2024 Earnings of ($0.48) Per Share Posted by Defense World Staff on Jan 25th, 202…
Sector: Pharmaceuticals
Ticker: ITCI
Sentiment: 0.8934
MarketCap: 6,360,377,747.0
High: 67.39 Low: 66.41

Open: 67.2 Close: 66.98 Change: -0.22

Read more →
...
December 20, 2023 18:54 (London Time)

Intra-Cellular Therapies

Intra-Cellular Therapies (ITCI) is a Great Momentum Stock: Should You Buy? Does Intra Intra-Cellular Therapies stock has received a consensus rating…
Sector: Pharmaceuticals
Ticker: ITCI
Sentiment: 0.4588
MarketCap: 6,303,597,253.0
High: 66.44 Low: 64.05

Open: 65.1 Close: 66.31 Change: 1.21

Read more →
...
November 24, 2023 5:45 (London Time)

Intra-Cellular Therapies

Intra-Cellular Therapies, Inc. the right play on intra-cellular therapies (nasdaq:itci) | seeking alpha. The Right Play On Intra.com: Seeking Alpha.…
Sector: Pharmaceuticals
Ticker: ITCI
Sentiment: 0.4767
MarketCap: 5,703,071,346.0
High: 60.25 Low: 58.34

Open: 59.71 Close: 59.26 Change: -0.45

Read more →
...
September 05, 2023 7:33 (London Time)

Intra-Cellular Therapies

Intra-Cellular Therapies, Inc. raised its stake in shares of Intra Cellular Therapsies by 11.7% in the 1st quarter. JPMorgan Chase & Co. increased i…
Sector: Pharmaceuticals
Ticker: ITCI
Sentiment: 0.5106
MarketCap: 5,367,674,765.0
High: 56.47 Low: 55.54

Open: 55.59 Close: 55.86 Change: 0.27

Read more →
...
January 01, 2024 7:30 (London Time)

Intra-Cellular Therapies

Intra-Cellular Therapies (NASDAQ: ITCI) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Bullish Indiffe…
Sector: Pharmaceuticals
Ticker: ITCI
Sentiment: -0.3862
MarketCap: 6,892,574,584.0
High: 72.18 Low: 70.81

Open: 71.74 Close: 71.62 Change: -0.12

Read more →
...
November 25, 2023 10:25 (London Time)

Intra-Cellular Therapies

Intra-Cellular Therapies ( NASDAQ:ITCI – Get Free Report ) last issued its earnings results on Thursday, November 2nd. The company had a negative re…
Sector: Pharmaceuticals
Ticker: ITCI
Sentiment: -0.6249
MarketCap: 5,718,469,446.0
High: 60.31 Low: 58.96

Open: 59.04 Close: 59.42 Change: 0.38

Read more →
...
November 02, 2023 8:06 (London Time)

Intra-Cellular Therapies

Intra-Cellular Therapies ITCI is set to give its latest quarterly earnings report on Thursday, 2023-11-02. Analysts estimate that Intra.Cellular. Th…
Sector: Pharmaceuticals
Ticker: ITCI
Sentiment: 0.296
MarketCap: 4,888,177,860.0
High: 50.92 Low: 49.3

Open: 49.9 Close: 50.87 Change: 0.97

Read more →
...
May 15, 2023 23:33 (London Time)

Intra-Cellular Therapies

Intra-Cellular Therapies (ITCI) shares soared 16.4% in the last trading session to close at $55.73. Arizona State Retirement System raised its holdi…
Sector: Pharmaceuticals
Ticker: ITCI
Sentiment: 0.5267
MarketCap: 6,072,077,883.0
High: 65.58 Low: 64.21

Open: 64.5 Close: 64.91 Change: 0.41

Read more →
Search
Happening Now
Categories